Sunday, October 12, 2025
Home Authors Posts by Ogkologos

Ogkologos

4034 POSTS 0 COMMENTS

Adagrasib Improves PFS Over Docetaxel in Patients with Previously Treated KRASG12C-mutated...

Ogkologos -
0

No Survival Benefit from Adding Adjuvant Chemotherapy to Endocrine Therapy in...

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Belantamab Mafodotin

Ogkologos -
0

ESMO Joins the European Health Alliance on Alcohol (EHAA) Seeking to...

Ogkologos -
0

CLDN18.2-Specific CAR T-Cell Therapy Prolongs PFS in Patients with Previously Treated...

Ogkologos -
0

FDA Approves Tafasitamab-cxix for Relapsed or Refractory Follicular Lymphoma

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Vorasidenib

Ogkologos -
0

Postoperative Radioiodine Can Be Avoided in Patients with Low-Risk Differentiated Thyroid...

Ogkologos -
0

A Combination of Talazoparib and Enzalutamide Prolongs OS in Unselected and...

Ogkologos -
0

ESMO Recommendations on Cancer Care Reflected in Un ECOSOC Ministerial Declaration...

Ogkologos -
0
1...567...404Page 6 of 404

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com